Production (Stage)
Perspective Therapeutics, Inc.
CATX
$2.39
-$0.12-4.78%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -47.97% | -62.79% | -46.02% | -5.38% | -3,211.05% |
| Total Depreciation and Amortization | 105.62% | 5,526.92% | 140.65% | 117.49% | 78.89% |
| Total Amortization of Deferred Charges | -- | 0.00% | -- | -- | -- |
| Total Other Non-Cash Items | 227.89% | 84.22% | 134.72% | -54.19% | 104.17% |
| Change in Net Operating Assets | -121.20% | -557.48% | 2,588.89% | 28.62% | 5,845.70% |
| Cash from Operations | -255.85% | -195.36% | 133.29% | -10.28% | 242.43% |
| Capital Expenditure | 48.68% | -16,320.22% | -12,989.43% | -82.88% | -4,413.43% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 97.62% | -- | -- | -12,566.67% | -267.92% |
| Cash from Investing | 88.23% | -155,632.58% | -13,000.00% | -475.04% | -287.23% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -8.33% | 0.00% | 23.81% | 60.00% | 20.00% |
| Issuance of Common Stock | -94.00% | -- | 2,827.27% | 22,849.62% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -94.00% | -1.99% | 62,700.00% | 23,744.53% | 208,010.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -112.92% | -1,785.23% | -149.06% | 1,451.13% | 759.56% |